Sign in
The image displays a flat lay arrangement of medical and hygiene items on a light-colored surface, likely a table or countertop, under indoor lighting. No individuals, actions, or direct interactions are visible.

From left to right and top to bottom:
1.  **Clear Plastic Bottle:** A transparent plastic bottle, approximately one-quarter full of a pinkish liquid, is positioned on the left. Its label, primarily white with French text, features "BACTERICIDE VIRUCIDE" and hazard symbols for flammability (flame pictogram) and irritation (exclamation mark).
2.  **Medication Box:** Behind the plastic bottle, a white rectangular cardboard box for "Kesimpta® 20 mg" is visible. The box is labeled in French, stating "solution injectable en stylo prérempli," "ofatumumab," "Voie sous-cutanée," and "1 stylo Sensoready® prérempli." The manufacturer "NOVARTIS" is printed on the box, which also features blue and orange horizontal bands on its sides.
3.  **Sterile Gauze Packet:** In the foreground, slightly left of center, lies a sealed, square packet of "soineo®" sterile gauze pads. The packet, white with blue accents, is labeled "2 compresses stériles de gaze," "8 ÉPAISSEURS," and "7,5 cm x 7,5 cm." It includes standard medical device symbols for sterility, single use, and "MD" (Medical Device), along with a CE 0123 mark. Distributor information on the packet identifies "SOINÉO - Rhône Park - 55L, route du Barrage - 69121 VAISE - FRANCE."
4.  **Instruction Manual:** To the right and partially covered by the gauze packet is a white instruction manual or booklet. Its prominent title reads "MODALITÉS D'UTILISATION du stylo Sensoready® Kesimpta®," with the "NOVARTIS" logo below. The top right corner of the manual indicates "DOCUMENT D'INFORMATIONS À DESTINATION DES PATIENTS Document diffusé sous l'autorité de l'ANSM 4 octobre 2021 - version 1," confirming a French regulatory context for the medication.

While the items suggest a French context for medical use (ANSM, French labeling), the image contains no specific visual or textual information to identify a precise location within the city of Strasbourg, France. The gauze packet lists a distributor address in Vaise, France (a district of Lyon).
N
N a m i 🐈‍⬛

Mar 7, 2026, 11:17 PM

Strasbourg, France

REMOVED

Stake attention in this memory

Concern
Anxiety
Hope
Relief
Medical

The image displays a flat lay arrangement of medical and hygiene items on a light-colored surface, likely a table or countertop, under indoor lighting. No individuals, actions, or direct interactions are visible. From left to right and top to bottom: 1. **Clear Plastic Bottle:** A transparent plastic bottle, approximately one-quarter full of a pinkish liquid, is positioned on the left. Its label, primarily white with French text, features "BACTERICIDE VIRUCIDE" and hazard symbols for flammability (flame pictogram) and irritation (exclamation mark). 2. **Medication Box:** Behind the plastic bottle, a white rectangular cardboard box for "Kesimpta® 20 mg" is visible. The box is labeled in French, stating "solution injectable en stylo prérempli," "ofatumumab," "Voie sous-cutanée," and "1 stylo Sensoready® prérempli." The manufacturer "NOVARTIS" is printed on the box, which also features blue and orange horizontal bands on its sides. 3. **Sterile Gauze Packet:** In the foreground, slightly left of center, lies a sealed, square packet of "soineo®" sterile gauze pads. The packet, white with blue accents, is labeled "2 compresses stériles de gaze," "8 ÉPAISSEURS," and "7,5 cm x 7,5 cm." It includes standard medical device symbols for sterility, single use, and "MD" (Medical Device), along with a CE 0123 mark. Distributor information on the packet identifies "SOINÉO - Rhône Park - 55L, route du Barrage - 69121 VAISE - FRANCE." 4. **Instruction Manual:** To the right and partially covered by the gauze packet is a white instruction manual or booklet. Its prominent title reads "MODALITÉS D'UTILISATION du stylo Sensoready® Kesimpta®," with the "NOVARTIS" logo below. The top right corner of the manual indicates "DOCUMENT D'INFORMATIONS À DESTINATION DES PATIENTS Document diffusé sous l'autorité de l'ANSM 4 octobre 2021 - version 1," confirming a French regulatory context for the medication. While the items suggest a French context for medical use (ANSM, French labeling), the image contains no specific visual or textual information to identify a precise location within the city of Strasbourg, France. The gauze packet lists a distributor address in Vaise, France (a district of Lyon).

Symbol

36D2E

Volume

0

Creator

+$0.00

Revenue

+$0.00

TVL

$0.00

1D
1W
1M
All

Loading AttnAds…

transactions
revenues
stakers
Earliest
Latest
Highest stake

1

Banky

Staked 4mo ago
Redeemed 4mo ago

$0.06 USD

-$0.00 USD

Fee: $0.00 (5%)

-6%

More from this user

More from Strasbourg

NN a m i 🐈‍⬛

Mar 7, 2026, 11:17 PM

Strasbourg, France

Licensed under Creative Commons Attribution 4.0 International License. You are free to share and adapt this content with proper attribution.